Rheumatology International

Papers
(The H4-Index of Rheumatology International is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Rheumatology university faculty opinion on coronavirus disease-19 (COVID-19) vaccines: the vaXurvey study from Egypt107
A hypothetical future in rheumatology: will we miss steroids in a steroid free-world?79
Cardiopulmonary exercise testing and prognosis in patients with systemic sclerosis without baseline pulmonary hypertension: a prospective cohort study78
COVID-19 pneumonia in a patient with granulomatosis with polyangiitis on rituximab: case-based review72
Cardiac involvement in primary Sjӧgren’s syndrome65
Demyelinating disease (multiple sclerosis) in a patient with psoriatic arthritis treated with adalimumab: a case-based review54
COVID-19 from a rheumatology perspective: bibliometric and altmetric analysis52
Protracted severe COVID-19 pneumonia following rituximab treatment: caution needed51
Epidemiology and genetics of granulomatosis with polyangiitis50
Risk factors of avascular necrosis in Takayasu arteritis: a cross sectional study49
Clinical performance of rheumatoid arthritis impact of disease score: a real-life evidence from the multicenter nationwide registry BioStaR43
Correction to: In vitro effects of curcumin on proinflammatory cytokines and expression of their genes in minor salivary gland tissue of patients with Sjogren’s syndrome39
Participation in physical activity decreased more in people with rheumatoid arthritis than the general population during the COVID-19 lockdown: a cross-sectional study39
Clonal expansion of large granular lymphocytes in patients with spondyloarthritis and psoriatic arthritis treated with TNFα inhibitors36
Large joints are progressively involved in rheumatoid arthritis irrespective of rheumatoid factor status—results from the early rheumatoid arthritis study35
Impact of the COVID-19 pandemic on the frequency of the pediatric rheumatic diseases34
The effects of golimumab on patient centric outcomes amongst rheumatoid arthritis patients in Greece. The GO-Q study33
Antibody response to inactivated COVID-19 vaccine (CoronaVac) in immune-mediated diseases: a controlled study among hospital workers and elderly30
Postdischarge rheumatic and musculoskeletal symptoms following hospitalization for COVID-19: prospective follow-up by phone interviews25
Assessment of sarcopenia in patients with fibromyalgia25
Alternatives for erroneous finger probe pulse oximetry in systemic sclerosis patients during COVID-19 pandemic24
Changing trends in rheumatoid arthritis mortality in Mexico, from 1998 to 201723
ANCA-associated vasculitis following ChAdOx1 nCoV19 vaccination: case-based review23
0.068014144897461